GSEA results demonstrated that cancer cell proliferation signatures were the top hits downregulated in tumors with low LGMN expression in TAMs (Figure 3A and Supplemental Figure 4, A and B), suggesting a connection between TAM-derived LGMN and cancer cell proliferation in GBM. The gene discussed is LGMN; the disease is glioblastoma.